Evidence map›Paper›PMID 28070721›Full record

ArticleJournal of industrial microbiology & biotechnology2017

Enhanced xylose fermentation by engineered yeast expressing NADH oxidase through high cell density inoculums.

Guo-Chang Zhang, Timothy L Turner, Yong-Su Jin

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of industrial microbiology & biotechnology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Xylo-Oligosaccharide Utilization by EngineeredFrontiers in bioengineering and biotechnology · 2022
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Guo-Chang ZhangCarl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, 1206 W. Gregory Drive, Urbana, IL, 61801, USA.
Timothy L TurnerDepartment of Food Science and Human Nutrition, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA.
Yong-Su JinCarl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, 1206 W. Gregory Drive, Urbana, IL, 61801, USA. ysjin@illinois.edu.ORCID 0000-0003-4081-0799
University of Illinois Urbana-Champaign · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulation of reduced byproducts such as glycerol and xylitol during xylose fermentation by engineered Saccharomyces cerevisiae hampers the economic production of biofuels and chemicals from cellulosic hydrolysates. In particular, engineered S. cerevisiae expressing NADPH-linked xylose reductase (XR) and NAD

Indexed as

FermentationAldehyde ReductaseBiofuelsD-Xylulose ReductaseEthanolGlucoseGlycerolIndustrial MicrobiologyLigninMicroorganisms, Genetically-ModifiedMultienzyme ComplexesNADH, NADPH OxidoreductasesPlasmidsProtein EngineeringSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsAldehyde ReductaseBiofuelsD-Xylulose ReductaseEthanolGlucoseGlycerolLigninlignocelluloseMultienzyme ComplexesNADH, NADPH OxidoreductasesNADH oxidaseSaccharomyces cerevisiae ProteinsXylitolXyloseEthanolHigh initial cell densitynoxESaccharomyces cerevisiaeXylose fermentation

Identifiers

PMID28070721
OpenAlexW2570475892

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.